The novel substituted acylproline-containing dipeptide, GVS-111, promotes the restoration of learning and memory impaired by bilateral frontal lobectomy in rats.
The present study investigated the potential benefit of the ethyl ester of N-phenylacetylprolylglycine (GVS-111) on the model of bilateral frontal lobectomy (BFL) in rats. The animals in Experiment 1 were trained in an active avoidance task and subsequently underwent BFL. The animals in Experiment 2 were first assessed in an open field and in a passive avoidance test before the BFL was performed. BFL dramatically decreased performance in the active avoidance test, disturbed habituation of horizontal activity in the open field and diminished the latency to enter the dark compartment in the passive avoidance test. GVS-111, administered in a dose of 0.5 mg/kg/day i.p. for 9 days following the operation, was found to improve performance in both active avoidance and passive avoidance and restored habituation of horizontal activity in the lobectomized animals.
Ostrovskaya
R U
RU
Institute of Pharmacology, Russian Academy of Medical Sciences, Moscow, Russia.
Romanova
G A
GA
Trofimov
S S
SS
Gudasheva
T A
TA
Voronina
T A
TA
Halikas
J A
JA
Seredenin
S B
SB
D000818:Animals; D004151:Dipeptides / Q000627:therapeutic use*; D005625:Frontal Lobe / Q000502:physiology*; D007859:Learning Disabilities / Q000188:drug therapy* / Q000209:etiology / Q000523:psychology; D008297:Male; D008569:Memory Disorders / Q000188:drug therapy* / Q000523:psychology; D009043:Motor Activity / Q000187:drug effects; D018697:Nootropic Agents / Q000627:therapeutic use*; D051381:Rats; D017208:Rats, Wistar
D004151:Dipeptides; D018697:Nootropic Agents; C103871:ethyl phenylacetyl-Pro-Gly